Standout Papers

An Algorithm for the Grading of Activity in Chronic Hepatitis C 1996 2026 2006 2016 3.3k
  1. An Algorithm for the Grading of Activity in Chronic Hepatitis C (1996)
    Pierre Bédossa, Thierry Poynard Hepatology
  2. Natural history of liver fibrosis progression in patients with chronic hepatitis C (1997)
    Thierry Poynard, Pierre Bédossa et al. The Lancet
  3. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (1998)
    Thierry Poynard, Patrick Marcellin et al. The Lancet
  4. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease (2005)
    Vlad Ratziu, Frédéric Charlotte et al. Gastroenterology
  5. Viral hepatitis B (2003)
    Ching‐Lung Lai, Vlad Ratziu et al. The Lancet
  6. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study (2001)
    Françoise Imbert‐Bismut, Vlad Ratziu et al. The Lancet
  7. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients (1999)
    Yves Benhamou, Marie Bochet et al. Hepatology
  8. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C (2002)
    Thierry Poynard, John G. McHutchison et al. Gastroenterology
  9. Liver fibrosis in overweight patients (2000)
    Vlad Ratziu, Philippe Giral et al. Gastroenterology
  10. Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C (2002)
    John G. McHutchison, Michael P. Manns et al. Gastroenterology
  11. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression (2009)
    Gary L. Davis, Miriam J. Alter et al. Gastroenterology
  12. Viral hepatitis C (2003)
    Thierry Poynard, Man‐Fung Yuen et al. The Lancet
  13. Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration (1996)
    Thierry Poynard, Vincent Leroy et al. Hepatology
  14. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C (2001)
    Thierry Poynard, Vlad Ratziu et al. Journal of Hepatology
  15. Liver Fibrosis in Viral Hepatitis: Noninvasive Assessment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography (2009)
    Mireen Friedrich‐Rust, K. Wunder et al. Radiology
  16. Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients With Gastrointestinal Bleeding: A Meta–Analysis (1999)
    Brigitte Bernard, Jean‐Didier Grangé et al. Hepatology
  17. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver (2013)
    Raluca Pais, Frédéric Charlotte et al. Journal of Hepatology

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 129 standout
Sub-graph 1 of 15

Citing Papers

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Use of Liver Imaging and Biopsy in Clinical Practice
2017 Standout
42 intermediate papers

Works of Thierry Poynard being referenced

Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis
2012
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
and 52 more

Author Peers

Author Last Decade Papers Cites
Thierry Poynard 35335 33163 4255 425 42.7k
Zachary Goodman 32446 30336 4296 293 40.9k
Jay H. Hoofnagle 29885 29585 4086 388 42.8k
Mitchell L. Shiffman 27020 27265 3005 269 33.5k
Adrian M. Di Bisceglie 23266 23261 2203 380 32.6k
Antonio Craxı̀ 19269 19193 2448 511 25.6k
Pierre Bédossa 27273 21759 5455 506 37.5k
Stefan Zeuzem 32059 33445 3983 1.0k 45.8k
Anna S. Lok 39673 38461 3804 553 46.8k
Vincent Wai‐Sun Wong 31784 20258 7469 619 42.6k
Norah A. Terrault 20430 19102 3727 451 25.7k

All Works

Loading papers...

Rankless by CCL
2026